The COVID-19 pandemic highlighted the critical importance of data communications for informing both decision-makers and the public to help save lives. Dashboards, catchy messages ("Flatten the Curve"), and other communication tools helped us to make sense of complex data and take life-saving action. At the same time, the downpour of graphs in the media during the early months of 2020 has demonstrated how misused or misunderstood scientific data can deceive and confuse. In this blog post we will share Quantori's perspective on data communication strategies, informed by years of working at the intersection of biotechnology and informatics. We will highlight the three pillars of communication approach in our field, which aim to ensure that scientific data is credible, actionable and accessible.

We are grateful to our speakers and engaged audience for driving a dynamic discussion. As David Walker, Quantori’s VP of Life Sciences, said: “The Q&A sparked thoughtful dialogue on how AI is reshaping competitive advantage across techbio, biotech, and pharma. While core AI capabilities are becoming increasingly standardized, true differentiation will come from innovative business models and flawless execution.”

Machine learning (ML) is transforming microbiome research, offering new ways to analyze complex biological data and unlock insights into human health. However, challenges such as small dataset sizes, demographic biases, and model validation issues must be addressed to ensure reliable and fair applications in clinical settings. Overcoming these hurdles will require collaboration across disciplines and adherence to best practices to maximize the potential of ML in microbiomics.

Pushing the Boundaries of AI in Pharma R&D: Insights from David Walker's Presentation

Quantori’s Cheminformatics department partnered with Nebius, recently embarked on a research initiative to develop a molecular generation pipeline leveraging stable diffusion and our own recent developments in the area of graph-convolutional networks.

Yesterday, we were excited to host our first Quantori Connect Roundtable! Bringing together industry leaders from Pfizer, Takeda, Vertex, and Applied Insights Consulting, we explored the value proposition of AI/ML in biopharma—discussing adoption challenges, real-world applications, and future opportunities.

Everest Group highlighted Quantori’s strong technology partner ecosystem, skilled talent pool, and investment in emerging technologies as key factors in its leadership position.

Save the date: October 9 at 11:45 and 12:05 to attend Orion Pharma's and Quantori's presentations.

Today, we are celebrating not just our company's 6th birthday but also the collective efforts and achievements that brought us here

Stop by our booth #B5 to say hello and connect with our experts